1. Medtronic posted its financial results for the second quarter of the fiscal year 2024, reporting a 5.3% revenue increase year over year with $8 billion.
2. Exactech’s Active Intelligence platform has been used in more than 100,000 joint replacements worldwide.
3. Boston Scientific closed its acquisition of Relievant Medsystems, which is behind the Intracept intraosseous nerve ablation system, for $850 million.
4. Aurora Spine announced its financial results for the third quarter of 2023, seeing a 7.7% growth in sales from the same quarter last year.
5. NGMedical GmbH’s Move-C device made its debut in Taiwan.
6. VySpine earned FDA clearance for its ClariVy OsteoVy PEKK device for one-level cervical interbody fusion.
